Significance and Function of HGAL in Lymphoma

HGAL 在淋巴瘤中的意义和功能

基本信息

项目摘要

Project Summary/Abstract This project is based on our findings that high expression of Human Germinal center Associated Lymphoma (HGAL) - a new gene that we cloned and characterized - is an independent predictor of prolonged survival of diffuse large B cell lymphoma (DLBCL) and Hodgkin's disease (HD) patients. Recently, we demonstrated that HGAL mediates IL-6-induced inhibition of germinal center (GC) B-cell migration. We demonstrated that IL-6 induces Lyn-mediated phosphorylation of the HGAL C-terminal tyrosine and causes HGAL relocalization to podosome-like structures and spike-like filopodia. We showed interactions between endogenous HGAL and myosin II and delineated HGAL domains responsible for the interaction. We provided evidence that HGAL phosphorylation results in increased interaction with the myosin II and demonstrated that knockdown of endogenous HGAL ameliorates the inhibitory effects of the IL-6 on cell migration. Taken together, these results identified HGAL as a physiological mediator of IL-6 effects on lymphocyte migration and suggest that HGAL expression in GC-derived lymphomas may limit tumor dissemination and predispose to better clinical outcome. However, despite the marked progress in identifying HGAL role in cellular processes, the precise mechanisms of HGAL-mediated inhibition of cell migration and consequent predisposition to better clinical outcome of tumors expressing HGAL are presently unknown. Our preliminary data demonstrates that HGAL may affect cell motility by interacting with myosin II and/or by increasing RoA activity. However, these effects need to be further investigated. In this project we will: 1) Determine effects of HGAL on myosin II function; 2) Determine effects of HGAL on a member of the small Rho GTPase family - RhoA protein and its effectors; 3) Determine the role of HGAL myristoylation and palmytoylation on its inhibitory effects on cell motility; and 4) Determine the effects of HGAL expression in transgenic mice model on lymphocyte differentiation, maturation, motility and lymphomagenesis. These studies will expand our knowledge on biology of the GC lymphocytes, with specific emphasis on lymphocyte motility and migration. Furthermore, these studies will reveal potentially new mechanisms regulating dissemination and progression of lymphoid tumors. These mechanistic studies may provide novel approaches for new therapeutic.
项目总结/文摘

项目成果

期刊论文数量(66)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma.
  • DOI:
    10.1002/ajh.23996
  • 发表时间:
    2015-06
  • 期刊:
  • 影响因子:
    12.8
  • 作者:
    Hosein, Peter J.;Sandoval-Sus, Jose D.;Goodman, Deborah;Arteaga, Alexandra Gomez;Reis, Isildinha;Hoffman, James;Stefanovic, Alexandra;Rosenblatt, Joseph D.;Lossos, Izidore S.
  • 通讯作者:
    Lossos, Izidore S.
Biased immunoglobulin light chain use in the Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas.
偏向免疫球蛋白轻链在鹦鹉热衣原体阴性眼附件边缘区淋巴瘤中的应用。
  • DOI:
    10.1002/ajh.23416
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    12.8
  • 作者:
    Zhu,Daxing;Lossos,Chen;Chapman-Fredricks,JenniferR;Lossos,IzidoreS
  • 通讯作者:
    Lossos,IzidoreS
Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas.
鹦鹉热衣原体阴性眼附件边缘区淋巴瘤的分子和基因组畸变。
  • DOI:
    10.1002/ajh.23490
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    12.8
  • 作者:
    Zhu,Daxing;Ikpatt,OffiongF;Dubovy,SanderR;Lossos,Chen;Natkunam,Yasodha;Chapman-Fredricks,JenniferR;Fan,Yao-Shan;Lossos,IzidoreS
  • 通讯作者:
    Lossos,IzidoreS
The age of the target cell affects B-cell leukaemia malignancy.
  • DOI:
    10.18632/aging.100244
  • 发表时间:
    2010-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Vicente-Dueñas C;Abollo-Jiménez F;Ruiz-Roca L;Alonso-Escudero E;Jiménez R;Cenador MB;Criado FJ;Cobaleda C;Sánchez-García I
  • 通讯作者:
    Sánchez-García I
Genetic background affects susceptibility to tumoral stem cell reprogramming.
  • DOI:
    10.4161/cc.25544
  • 发表时间:
    2013-08-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    García-Ramírez I;Ruiz-Roca L;Martín-Lorenzo A;Blanco O;García-Cenador MB;García-Criado FJ;Vicente-Dueñas C;Sánchez-García I
  • 通讯作者:
    Sánchez-García I
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IZIDORE S LOSSOS其他文献

IZIDORE S LOSSOS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IZIDORE S LOSSOS', 18)}}的其他基金

Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL
确定 LMO2 介导的同源重组抑制机制并建立 PARP 靶向合成致死作为 DLBCL 的新疗法
  • 批准号:
    9900766
  • 财政年份:
    2019
  • 资助金额:
    $ 22.86万
  • 项目类别:
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL
确定 LMO2 介导的同源重组抑制机制并建立 PARP 靶向合成致死作为 DLBCL 的新疗法
  • 批准号:
    10378494
  • 财政年份:
    2019
  • 资助金额:
    $ 22.86万
  • 项目类别:
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCL
确定 LMO2 介导的同源重组抑制机制并建立 PARP 靶向合成致死作为 DLBCL 的新疗法
  • 批准号:
    10599232
  • 财政年份:
    2019
  • 资助金额:
    $ 22.86万
  • 项目类别:
Prognostic Models in Diffuse Large B-Cell Lymphoma
弥漫性大 B 细胞淋巴瘤的预后模型
  • 批准号:
    7676701
  • 财政年份:
    2007
  • 资助金额:
    $ 22.86万
  • 项目类别:
Prognostic Models in Diffuse Large B-Cell Lymphoma
弥漫性大 B 细胞淋巴瘤的预后模型
  • 批准号:
    7379862
  • 财政年份:
    2007
  • 资助金额:
    $ 22.86万
  • 项目类别:
Prognostic Models in Diffuse Large B-Cell Lymphoma
弥漫性大 B 细胞淋巴瘤的预后模型
  • 批准号:
    7500654
  • 财政年份:
    2007
  • 资助金额:
    $ 22.86万
  • 项目类别:
Prognostic Models in Diffuse Large B-Cell Lymphoma
弥漫性大 B 细胞淋巴瘤的预后模型
  • 批准号:
    7880670
  • 财政年份:
    2007
  • 资助金额:
    $ 22.86万
  • 项目类别:
Significance and Function of HGAL in Lymphoma
HGAL 在淋巴瘤中的意义和功能
  • 批准号:
    8054687
  • 财政年份:
    2005
  • 资助金额:
    $ 22.86万
  • 项目类别:
Significance and Function of HGAL in Lymphoma
HGAL 在淋巴瘤中的意义和功能
  • 批准号:
    7046800
  • 财政年份:
    2005
  • 资助金额:
    $ 22.86万
  • 项目类别:
Significance and Function of HGAL in Lymphoma
HGAL 在淋巴瘤中的意义和功能
  • 批准号:
    6918441
  • 财政年份:
    2005
  • 资助金额:
    $ 22.86万
  • 项目类别:

相似国自然基金

由actomyosin介导的集体性细胞迁移对唇腭裂发生的影响的研究
  • 批准号:
    82360313
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Nuclear force feedback as rheostat for actomyosin tension control
核力反馈作为肌动球蛋白张力控制的变阻器
  • 批准号:
    MR/Y001125/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.86万
  • 项目类别:
    Research Grant
CAREER: Cytokinesis without an actomyosin ring and its coordination with organelle division
职业:没有肌动球蛋白环的细胞分裂及其与细胞器分裂的协调
  • 批准号:
    2337141
  • 财政年份:
    2024
  • 资助金额:
    $ 22.86万
  • 项目类别:
    Continuing Grant
CAREER: Computational and Theoretical Investigation of Actomyosin Contraction Systems
职业:肌动球蛋白收缩系统的计算和理论研究
  • 批准号:
    2340865
  • 财政年份:
    2024
  • 资助金额:
    $ 22.86万
  • 项目类别:
    Continuing Grant
Elucidation of the mechanism by which actomyosin emerges cell chirality
阐明肌动球蛋白出现细胞手性的机制
  • 批准号:
    23K14186
  • 财政年份:
    2023
  • 资助金额:
    $ 22.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Deciphering actomyosin contractility regulation during incomplete germ cell division
破译不完全生殖细胞分裂过程中肌动球蛋白收缩性的调节
  • 批准号:
    573067-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 22.86万
  • 项目类别:
    University Undergraduate Student Research Awards
CAREER: Actuating robots with actomyosin active gels
职业:用肌动球蛋白活性凝胶驱动机器人
  • 批准号:
    2144380
  • 财政年份:
    2022
  • 资助金额:
    $ 22.86万
  • 项目类别:
    Continuing Grant
Collaborative Research: Mechanics of Reconstituted Self-Organized Contractile Actomyosin Systems
合作研究:重建自组织收缩肌动球蛋白系统的力学
  • 批准号:
    2201236
  • 财政年份:
    2022
  • 资助金额:
    $ 22.86万
  • 项目类别:
    Standard Grant
Collaborative Research: Mechanics of Reconstituted Self-Organized Contractile Actomyosin Systems
合作研究:重建自组织收缩肌动球蛋白系统的力学
  • 批准号:
    2201235
  • 财政年份:
    2022
  • 资助金额:
    $ 22.86万
  • 项目类别:
    Standard Grant
Coordination of actomyosin and anillo-septin sub-networks of the contractile ring during cytokinesis
胞质分裂过程中收缩环肌动球蛋白和 anillo-septin 子网络的协调
  • 批准号:
    463633
  • 财政年份:
    2022
  • 资助金额:
    $ 22.86万
  • 项目类别:
    Operating Grants
The integrin-dependent B cell actomyosin network drives immune synapse formation and B cell functions
整合素依赖性 B 细胞肌动球蛋白网络驱动免疫突触形成和 B 细胞功能
  • 批准号:
    546047-2020
  • 财政年份:
    2021
  • 资助金额:
    $ 22.86万
  • 项目类别:
    Postdoctoral Fellowships
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了